You are currently viewing a new version of our website. To view the old version click .

Antibodies, Volume 14, Issue 1

March 2025 - 26 articles

Cover Story: The elicitation of broadly neutralizing antibodies (bnAbs) is a major goal of vaccine design for highly mutable pathogens, such as influenza, HIV, and coronavirus. Although many rational vaccine design strategies for eliciting bnAbs have been devised, their efficacies need to be evaluated in preclinical animal models and in clinical trials. To improve outcomes for such vaccines, it would be useful to develop methods that can predict vaccine efficacies against arbitrary pathogen variants. As a step in this direction, here, we describe a simple biologically motivated model of antibody reactivity elicited by nanoparticle-based vaccines using only antigen amino acid sequences, parametrized with a small sample of experimental antibody binding data from influenza or SARS-CoV-2 nanoparticle vaccinations. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (26)

  • Review
  • Open Access
2 Citations
4,551 Views
19 Pages

18 March 2025

Advanced gastric adenocarcinoma (GAC) carries a poor prognosis. Targeted therapy in GAC has traditionally been limited to anti-human epidermal growth factor receptor-2 and anti-vascular endothelial growth factor agents. Recent years have brought immu...

  • Review
  • Open Access
1 Citations
2,060 Views
10 Pages

Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?

  • Han Sean Lee,
  • Henry H. L. Wu,
  • Arvind Ponnusamy,
  • Helen Alderson and
  • Rajkumar Chinnadurai

12 March 2025

Diabetic nephropathy (DN) is one of the key causes of end-stage kidney disease worldwide, especially in developed countries. The classic pathogenic development of DN is characterized by microalbuminuria which would progress to nephrotic-range protein...

  • Review
  • Open Access
3 Citations
3,815 Views
16 Pages

10 March 2025

Autoantibodies to ADAMTS13 are at the center of pathology of the immune-mediated thrombotic thrombocytopenic purpura. These autoantibodies can be either inhibitory (enzymatic function) or non-inhibitory, resulting in protein depletion. Under normal p...

  • Article
  • Open Access
1 Citations
1,485 Views
16 Pages

The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2

  • Vazirbek S. Aripov,
  • Anna V. Zaykovskaya,
  • Ludmila V. Mechetina,
  • Alexander M. Najakshin,
  • Alexander A. Bondar,
  • Sergey G. Arkhipov,
  • Egor A. Mustaev,
  • Margarita G. Ilyina,
  • Sophia S. Borisevich and
  • Alexander A. Ilyichev
  • + 5 authors

Background: Since the emergence of SARS-CoV-2 in the human population, the virus genome has undergone numerous mutations, enabling it to enhance transmissibility and evade acquired immunity. As a result of these mutations, most monoclonal neutralizin...

  • Review
  • Open Access
2 Citations
4,750 Views
24 Pages

Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies

  • Dmitriy N. Shcherbakov,
  • Anastasiya A. Isaeva and
  • Egor A. Mustaev

Ebola virus disease (EVD) is an acute illness with a high-case fatality rate (CFR) caused by an RNA virus belonging to the Filoviridae family. Over the past 50 years, regular EVD outbreaks have been reported. The West African EVD outbreak of 2013&nda...

  • Communication
  • Open Access
2 Citations
2,782 Views
14 Pages

Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy

  • Seungmin Shin,
  • Du-San Baek,
  • John W. Mellors,
  • Dimiter S. Dimitrov and
  • Wei Li

Background: Macrophages play an important role in eliminating diseased and damaged cells through programmed cell death. Signal regulatory protein alpha (SIRPα) is a crucial immune checkpoint primarily expressed on myeloid cells and macrophages....

  • Review
  • Open Access
1,997 Views
23 Pages

26 February 2025

The rapid rise in monkeypox virus infections among humans from 2022 to 2024 has captured the attention of the global healthcare community. In light of the lack of mandatory vaccination and limited data on next-generation vaccines for monkeypox preven...

  • Article
  • Open Access
1,504 Views
11 Pages

IgE-Crosslinking-Induced Luciferase Expression Test as a Sensitive Indicator of Anisakis Allergy

  • Haruyo Akiyama,
  • Masashi Niwa,
  • Chisato Kurisaka,
  • Yuto Hamada,
  • Yuma Fukutomi and
  • Reiko Teshima

25 February 2025

Background: Anisakis allergy has been increasing, and the diagnosis of it is based on specific serum IgE detection. Recently, the IgE-crosslinking-induced luciferase expression (EXiLE) test has been proposed as convenient tool for detecting func...

  • Review
  • Open Access
4 Citations
3,581 Views
17 Pages

Avian Antibodies as Potential Therapeutic Tools

  • Mats Eriksson and
  • Anders Larsson

14 February 2025

Immunoglobulin Y (IgY) is the primary antibody found in the eggs of chicken (Gallus domesticus), allowing for large-scale antibody production with high titers, making them cost-effective antibody producers. IgY serves as a valuable alternative to mam...

  • Article
  • Open Access
1,918 Views
22 Pages

13 February 2025

Objectives: To investigate the pharmacokinetics (PK) of the monoclonal antibody (mAb) in male reproductive tissues and develop a translational physiologically based pharmacokinetic (PBPK) model to characterize the PK data. Method: The PK of a non-cro...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibodies - ISSN 2073-4468